Epic launches program to ‘unify’ clinical research with care delivery

By Ben Hargreaves

- Last updated on GMT

© Joseph Reynolds / Getty Images
© Joseph Reynolds / Getty Images

Related tags Clinical trials Patient recruitment

Epic’s Life Sciences program is released with the aim to connect providers, pharmaceutical companies, and medical device manufacturers to recruit research participants, expand clinical trial access, and to speed up therapy development.

On the launch, Epic stated that it plans to unite each of the stakeholders through the use of a single system, the Life Sciences program. According to the company, providers globally are using Epic to conduct more than 100,000 active research studies, which feature approximately 4.7 million patients.

With the Life Sciences program, Epic will focus on matching providers with clinical trials suited to the makeup of their patient populations, which the company states will be available at launch. Extending beyond this, Alan Hutchison, VP, population, health and payer strategy at Epic, told Outsourcing-Pharma that the company’s R&D team is currently working on the next components of the roadmap for the Life Sciences program.

The release states that Epic has four further aims beyond clinical trial matching: making clinical trials accessible, increasing clinical trial efficiency, supporting clinicians with point-of-care insights, and to deliver purpose-built searches to providers to assess whether a trial is right for them.

The overall goal, according to Hutchison, is to create, “A unified infrastructure that connects all aspects of healthcare—including providers, patients, payers, specialty diagnostics labs, life sciences companies, and more—can foster higher quality care, a more cohesive healthcare experience, and more rapid medical innovation.”

Epic stated that the Life Sciences program would expand clinical trial access, including to underrepresented communities, which is a major talking point across the industry​. Hutchison clarified that improving access could be thought of as a two-stage process, in regard to study sites and individual patients.

In terms of study sites, the clinical trial matchmaking allows sponsors to connect with provider organizations to treat diverse patient populations. The outcome for participating provider sites will be to receive more clinical trial opportunities suited to their patients, Hutchison outlined. Epic is also working to lower the technical and staffing barriers to entry for study site participation, expanding access to both providers and patients.

For the patients, Hutchison said, “Providers can share study opportunities with patients directly through MyChart, which more than 155 million US patients use to manage their care today. We’re further enhancing this patient-driven workflow by creating a single landing spot in MyChart where patients will be able to browse studies happening across the Epic community that suit their unique genomic profiles, medical histories, and research preferences.”

In addition, providers will be able to see real-time, in-workflow alerts that indicate when their patients’ clinical data indicate that they qualify for a clinical trial.

Related products

show more

Drug Solubility and the Need for Speed

Drug Solubility and the Need for Speed

Lonza Small Molecules | 28-Mar-2023 | Technical / White Paper

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us


View more